# Maraviroc Compassionate Use

> **NCT00719823** · PHASE3 · WITHDRAWN · sponsor: **ViiV Healthcare**

## Conditions studied

- Human Immunodeficiency Virus Type 1

## Interventions

- **DRUG:** Maraviroc

## Key facts

- **NCT ID:** NCT00719823
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-08
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00719823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00719823, "Maraviroc Compassionate Use". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00719823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*